PharmacoEconomics · 2016 · 99 citations · 26 references
BusinessDecision SciencesDecision AnalysisDecision MakingHealth Technology AssessmentCriteria SelectionDecision-analytic ModelingMedical Technology AssessmentMulti-criteria Decision AnalysisTechnology AssessmentValue AssessmentAdoption Of Medical TechnologiesHealthcare Decision-makingMulti-attribute Utility TheoryMultiattribute Value TheoryRobust Multi-criteria Decision AnalysisTechnology AppraisalValue-based Decision MakingValue-based Decision-making
MCDA has emerged as a holistic alternative to address shortcomings in health technology assessment, but its validity hinges on careful selection of criteria and attributes. The paper argues that MCDA must follow robust methodological processes for selecting objectives, criteria, and attributes to be meaningful in healthcare decision making and value‑based assessment. The authors propose a five‑phase multi‑attribute value theory process that outlines each stage and its relevance to the HTA workflow. When followed, the process gives decision makers a more complete value assessment, captures relative importance of criteria, and incorporates stakeholder preferences, all with full transparency to aid decision making.
In recent years, multiple criteria decision analysis (MCDA) has emerged as a likely alternative to address shortcomings in health technology assessment (HTA) by offering a more holistic perspective to value assessment and acting as an alternative priority setting tool. In this paper, we argue that MCDA needs to subscribe to robust methodological processes related to the selection of objectives, criteria and attributes in order to be meaningful in the context of healthcare decision making and fulfil its role in value-based assessment (VBA). We propose a methodological process, based on multi-attribute value theory (MAVT) methods comprising five distinct phases, outline the stages involved in each phase and discuss their relevance in the HTA process. Importantly, criteria and attributes need to satisfy a set of desired properties, otherwise the outcome of the analysis can produce spurious results and misleading recommendations. Assuming the methodological process we propose is adhered to, the application of MCDA presents three very distinct advantages to decision makers in the context of HTA and VBA: first, it acts as an instrument for eliciting preferences on the performance of alternative options across a wider set of explicit criteria, leading to a more complete assessment of value; second, it allows the elicitation of preferences across the criteria themselves to reflect differences in their relative importance; and, third, the entire process of preference elicitation can be informed by direct stakeholder engagement, and can therefore reflect their own preferences. All features are fully transparent and facilitate decision making.
26